The 90-subject study found that after three MDMA-assisted therapy sessions, 67% of participants with PTSD no longer qualified for that diagnosis, while 88% experienced a significant reduction in ...
also known as MDMA-assisted therapy, in August 2024, the regulator explained that it could not approve the treatment based on the data submitted to date. Instead, the agency requested that Lykos ...